Vimian Group AB (publ)
STO: VIMIAN.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Alireza Tajbakhsh
- Employees
- 1,200
- Headquarters
- Stockholm, Sweden
- IPO year
- 2021
- Market cap
- SEK 16.1B
- Website
- https://vimian.com
Loading VIMIAN…
Loading profile data…Frequently asked questions about VIMIAN
What does Vimian Group AB (publ) (VIMIAN.ST) do?
Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nex...
Where does VIMIAN.ST trade?
Vimian Group AB (publ) (VIMIAN.ST) trades on the Stockholm Stock Exchange.
What sector is VIMIAN.ST in?
Vimian Group AB (publ) (VIMIAN.ST) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Vimian Group AB (publ)?
Alireza Tajbakhsh is the chief executive officer of Vimian Group AB (publ) (VIMIAN.ST).
Where is Vimian Group AB (publ) headquartered?
Vimian Group AB (publ) is headquartered in Sweden.
Does VIMIAN.ST pay a dividend?
Vimian Group AB (publ) (VIMIAN.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VIMIAN.ST go public?
Vimian Group AB (publ) (VIMIAN.ST) completed its initial public offering in 2021.